Related Experiment Video
Updated: Jul 26, 2025

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
Promising therapeutic potential of tumor suppressor microRNAs for malignant pleural mesothelioma
Shivani Dixit1, Agnes Y Choi1, Anand Singh1
1Thoracic Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Abstract:
Malignant pleural mesothelioma (MPM) is an aggressive and recalcitrant surface neoplasm that defies current multimodality treatments. MicroRNAs (miRNAs) are small noncoding RNAs that epigenetically regulate multiple gene networks and cellular processes. In cancer, miRNA dysregulation is associated with tumorigenesis, with tumor suppressor miRNAs underexpressed or lost, while oncogenic miRNAs are overexpressed. Consequently, miRNAs have emerged as potential therapeutic candidates. Because loss of tumor suppressors predominates the pathophysiology of MPM, re-expressing tumor suppressor miRNAs could be an effective therapeutic strategy. This review highlights the most promising MPM-specific tumor suppressor miRNAs that could be developed into novel therapeutics, the supporting data, and what is known about their molecular mechanism(s).
Insights
Malignant pleural mesothelioma (MPM) is a challenging cancer. Re-expressing specific tumor suppressor microRNAs (miRNAs) offers a promising therapeutic strategy by targeting key gene networks involved in cancer development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Malignant pleural mesothelioma (MPM) is an aggressive cancer with limited treatment options.
- MicroRNAs (miRNAs) are small noncoding RNAs that regulate gene expression and are often dysregulated in cancer.
- Tumor suppressor miRNAs are frequently underexpressed in cancers, including MPM.
Purpose of the Study:
- To review promising tumor suppressor miRNAs specific to MPM.
- To explore their potential as novel therapeutic agents.
- To summarize supporting data and known molecular mechanisms.
Main Methods:
- Literature review of studies on miRNAs in MPM.
- Analysis of miRNA dysregulation in MPM pathophysiology.
- Identification of MPM-specific tumor suppressor miRNAs.
Main Results:
- Several tumor suppressor miRNAs show potential for MPM therapy.
- Dysregulation of these miRNAs is linked to MPM development.
- Understanding their molecular mechanisms is crucial for therapeutic development.
Conclusions:
- Re-expressing tumor suppressor miRNAs is a viable therapeutic strategy for MPM.
- Targeting specific miRNAs could overcome treatment resistance in MPM.
- Further research into MPM-specific miRNAs may lead to new treatments.
Related Concept Videos
MicroRNAs
Abnormal Proliferation
Mesenchymal Stem Cells
Pleural Disorders: Types and Brief Description

